Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration

被引:51
作者
Patmore, L [1 ]
Fraser, S [1 ]
Mair, D [1 ]
Templeton, A [1 ]
机构
[1] Heriot Watt Univ, Quintiles Scotland Ltd, Dept Pharmacol, Edinburgh EH14 4AP, Midlothian, Scotland
关键词
fluoroquinolones; sparfloxacin; moxifloxacin; grepafloxacin; ciprofloxacin; (canine); Purkinje fibre; cardiac action potential;
D O I
10.1016/S0014-2999(00)00694-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Fluoroquinolone antibiotics have been associated with QT prolongation following administration to humans. This study compares the effects of four fluoroquinolones, sparfloxacin, grepafloxacin, moxifloxacin and ciprofloxacin enaction potential duration recorded from canine isolated cardiac Purkinje fibres. Left and right ventricular Purkinje fibres were isolated from canine hearts and continuously superfused with physiological salt solution. Action potential duration at 90% repolarization was recorded via intracellular microelectrodes. Sparfloxacin, grepafloxacin, moxifloxacin and ciprofloxacin prolonged action potential duration in a concentration dependent manner. Mean concentrations causing a 15% prolongation of action potential duration recorded at a stimulation frequency of 1 Hz were: sparfloxacin 4.2 +/- 0.7 mug/ml; grepafloxacin 9.3 +/- 0.9 mug/ml; moxifloxacin 9.9 +/- 1.6 mug/ml and ciprofloxacin 72.8 +/- 26.4 mug/ml. Prolongation was inverse frequency dependent with larger increases in action potential duration occurring when the stimulation frequency was reduced to 0.5 Hz. These results indicate that effects on action potential duration vary within this class of compound. Rank order of potency was sparfloxacin > grepafloxacin = moxifloxacin > ciprofloxacin. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:449 / 452
页数:4
相关论文
共 19 条
[1]   Sparfloxacin but not levofloxacin or ofloxacin prolongs cardiac repolarization in rabbit Purkinje fibers [J].
Adamantidis, MM ;
Dumotier, BM ;
Caron, JF ;
Bordet, R .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1998, 12 (01) :70-76
[2]   Quinolone activity against anaerobes [J].
Appelbaum, PC .
DRUGS, 1999, 58 (Suppl 2) :60-64
[3]   Quinolone-induced QT interval prolongation: a not-so-unexpected class effect [J].
Ball, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (05) :557-559
[4]   Effects of fluoroquinolones on HERG currents [J].
Bischoff, U ;
Schmidt, C ;
Netzer, R ;
Pongs, O .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 406 (03) :341-343
[5]   A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new 'respiratory quinolones' [J].
Blondeau, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 :1-11
[6]   PHARMACOKINETICS AND TISSUE PENETRATION OF THE NEW FLUOROQUINOLONE GREPAFLOXACIN [J].
CHILD, J ;
ANDREWS, JM ;
WISE, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :513-515
[7]   A MOLECULAR-BASIS FOR CARDIAC-ARRHYTHMIA - HERG MUTATIONS CAUSE LONG QT SYNDROME [J].
CURRAN, ME ;
SPLAWSKI, I ;
TIMOTHY, KW ;
VINCENT, GM ;
GREEN, ED ;
KEATING, MT .
CELL, 1995, 80 (05) :795-803
[8]   Torsades de pointe probably related to sparfloxacin [J].
Dupont, H ;
Timsit, JF ;
Souweine, B ;
Gachot, B ;
Wolff, M ;
Regnier, B .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (04) :350-351
[9]   Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males [J].
Efthymiopoulos, C ;
Bramer, SL ;
Maroli, A .
CLINICAL PHARMACOKINETICS, 1997, 33 (Suppl 1) :1-8
[10]  
Geddes A M, 1999, Expert Opin Investig Drugs, V8, P487, DOI 10.1517/13543784.8.4.487